RedHill Biopharma Ltd.

NasdaqCM:RDHL Stock Report

Market Cap: US$7.8m

RedHill Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RDHL?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1870.0146%
Individual Insiders3,1260.244%
Institutions36,5992.86%
VC/PE Firms67,2545.25%
General Public1,173,37391.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 8.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.25%
Heights Capital Management, Inc.
67,254US$407.6k-3.92%0.07%
2.02%
Empery Asset Management, LP
25,913US$157.0k0%2.06%
0.4%
GAMMA Investing LLC
5,089US$30.8k0%no data
0.31%
Fédération des Caisses Desjardins du Québec, Asset Management Arm
3,992US$24.2k-0.08%no data
0.076%
Rhumbline Advisers Ltd Partnership
979US$5.9k29.3%no data
0.061%
Kenneth Reed
780US$4.7k0%no data
0.041%
Shmuel Cabilly
520US$3.2k0%no data
0.031%
Osaic Wealth, Inc. , Asset Management Arm
396US$2.4k0%no data
0.031%
Dror Ben-Asher
391US$2.4k0%no data
0.021%
Adi Frish
265US$1.6k0%no data
0.019%
Gilead Raday
244US$1.5k0%no data
0.015%
R & S United Services, Inc.
187US$1.1k0%no data
0.014%
Reza Fathi
180US$1.1k0%no data
0.014%
Morgan Stanley, Investment Banking and Brokerage Investments
180US$1.1k1,190%no data
0.013%
Razi Ingber
167US$1.0k0%no data
0.013%
Guy Goldberg
164US$994.10%no data
0.01%
Avi Polischuk
132US$800.10%no data
0.0095%
Eric Swenden
122US$739.50%no data
0.0089%
Rick Scruggs
114US$690.60%no data
0.0017%
Group One Trading LP, Asset Management Arm
22US$133.5-8.33%no data
0.0013%
Alla Felder
16US$97.00%no data
0.0013%
Regina Polischuk
16US$97.00%no data
0.0012%
Ofer Tsimchi
15US$90.80%no data
0.0011%
Yorkville Asset Management Inc.
14US$84.60%no data
0.00039%
Capital Performance Advisors LLP
5US$30.30%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 22:59
End of Day Share Price 2025/01/30 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RedHill Biopharma Ltd. is covered by 11 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
null nullBTIG
Brandon FolkesCantor Fitzgerald & Co.